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Overweight and obesity in type 2 diabetes. 
Abstract 
‘Diabesity’, the comorbid occurrence of type 2 diabetes (T2DM) with obesity, is increasing 
rapidly in the UK, and becoming more prevalent in younger age groups. The onset of diabetes 
increases risk of macro- and microvascular complications, reduced life expectancy, and 
decreased economic productivity and quality of life. It is also expensive to manage, through 
medication costs, monitoring, and management of complications. 
Management of obesity can improve diabetes control, but weight loss is often slower than in 
those without diabetes. This is often made more challenging over time, with disease 
progression increasing the number of medications required for glycaemic control. 
Dietary methods for weight loss in diabesity have been explored; restricting energy intake 
and regular support appears to be of more importance to success than macronutrient 
balance, although long-term effectiveness is unclear. However, bariatric surgery is the only 
current treatment option offering both the possibility of diabetes remission as well as 
substantial long-term weight loss. 
Specialist diabesity services, supported by a multidisciplinary team to manage outcomes for 
obesity and diabetes concurrently, have been piloted. However, these services are not 
commonly available at local level. It is unclear whether the existing obesity management 
service provision is adequately supporting weight loss for those with comorbid type 2 
diabetes.  
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Introduction 
‘Diabesity’ describes the occurrence of type 2 diabetes (T2DM) in obesity. As levels of both 
obesity and diabetes have risen in the UK in recent decades (Gonzalez, Johansson, Wallander 
& Rodriguez, 2009) weight loss is acknowledged as an important part of diabetes 
management (Lau & Teoh, 2013). There is limited high-quality large-scale trials informing 
formal dietary guidelines for obesity management in T2DM, and dietary composition is 
considered to be less important than creating an energy deficit (Diabetes UK, 2011). However, 
studies into the effect of different dietary strategies are ongoing, and in this literature review 
evidence behind common approaches are summarised. 
In addition, what is known about the physiological causes of diabesity is discussed, and the 
risks of the rise of diabesity to the individual and to health service provision is consolidated. 
Evidence consistently supports the use of bariatric surgery as a diabetes management – or 
indeed remission – strategy (Arterburn et al., 2013), but recent pilot schemes designed to 
tackle both the diabetes and obesity aspects of diabesity holistically have shown promise, and 
these are also explored. 
 
Diabetes and obesity as a growing concern  
Globally, diabetes is increasing in prevalence, exceeding projected estimates previously made 
(Guariguata et al., 2014). In the UK, prevalence has risen from 2.8% of adults in 1996, to 4.3% 
of adults in 2005 (Gonzalez, Johansson, Wallander & Rodriguez, 2009). It is currently 
estimated that nearly 3 million adults (between 20 and 79 years) in the United Kingdom have 
diabetes (Guariguata et al., 2014). Around 90% of those with diabetes have type 2 (NHS 
Choices, 2012). In part the rise in the UK over recent decades may be attributed to the 
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increased ethnic diversity of its population (Abate & Chandalia, 2003), and to the ageing 
population developing diabetes in later life (Diabetes UK, 2012). However predominantly the 
rise in diabetes can be contributed to the increase in obesity as the most influential risk factor 
for T2DM (Diabetes UK, 2012). 
Incidence in the UK has also increased in younger age groups, the proportion of diabetes 
diagnoses occurring across age groups shifted towards younger adults between 1991 and 
2000. This is likely to be due to a higher number of younger adults developing T2DM (Holden 
et al., 2013), but may also reflect improved screening of younger adults and diagnosis at its 
earlier stages. 
The nature of the relative risk between increased body mass index (BMI) and onset of 
diabetes is debated. Studies have independently suggested that for each additional BMI unit 
the relative risk of developing T2DM increased linearly by 1.18 (Hartemink, Boshuizen, 
Nagelkerke, Jacobs, & van Houwelingen, 2006, Schmidt et al., 2013), whereas other studies 
have suggested a non-linear relationship (Abdullah, Peeters, de Courten & Stoelwinder, 
2010). Accepting that multiple confounding modifiable and non-modifiable factors could 
impact on the risk of an individual developing T2DM, a meta-analysis of international studies 
concluded that an overweight person (BMI 25 to 30 kg/m2) incurs three times the risk of 
developing T2DM, and an obese person (BMI >30kg/m2) is seven times more at risk, compared 
to someone of BMI <25kg/m2 (Abdullah, Peeters, de Courten & Stoelwinder, 2010). 
The metabolic link between obesity and T2DM is twofold: firstly as a consequence of 
increased non-esterified fatty acids (NEFAs) in the liver and circulating from the adipose 
tissue. NEFAs taken up by the pancreas inhibit insulin secretion, and free fatty acids taken up 
by muscle tissue and in the liver reduce insulin signalling, which in combination leads to insulin 
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resistance (Lau & Teoh, 2013). In addition, production of some glucose-regulating hormones 
occurs in adipose tissue, which, when in excess, can lead to increased hormone production 
and further insulin resistance (Thevenod, 2008). 
Once diabetes has developed, risk of myocardial infarction and cerebrovascular accident 
increases by at least double (Lau & Teoh, 2013), as well as microvascular complications - 
commonly retinopathy, neuropathy, and nephropathy. Twenty years after onset, 80% of 
those with T2DM will have developed microvascular complications (Neff & le Roux, 2013). 
The development of atherosclerosis incurring further medical complications is linked to a 
decreased life expectancy of 10 years or more (Lau & Teoh, 2013). 
Because of the severity of these complications, diabetes requires intensive and potentially 
expensive management. A US study in 2013 collated costings data from the range of aspects 
involved in diabetes care (Zhou, Zhang & Hoerger, 2013), and concluded that mean lifetime 
cost of diabetes management was around $85, 000 (£50, 000) per person, which combined 
the costs of direct care including medication and input from healthcare professionals, and the 
indirect cost of treating macro- and microvascular complications. However, lifetime cost 
depended on age of onset – with those diagnosed at a younger age having a higher lifetime 
mean cost. Gender also played a role: women were found to have a slightly higher mean 
lifetime cost of diabetes, which the authors attribute to their longer life expectancy. In 
addition diabetes has an impact on the wider economy through absenteeism and inability to 
work through comorbidity-related disability (Yang et al., 2013). 
The number of people with diabetes in the UK is currently predicted to increase to over 3.6 
million by 2035 (Guariguata et al., 2014), and with it the financial burden to health and social 
services. The UK cost in 2010/11 of T2DM was estimated at £21.8 billion, including direct 
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medical care and wider costs: this is estimated to rise to £35.6 billion by 2035/36 (Hex, 
Bartlett, Wright, Taylor & Varley, 2012), an increase of 63%, and a proportionate rise from 
10% of NHS outgoings to 17%. These estimates have been based on the assumption that costs 
of care are not altered considerably – although it is possible that treatment options such as 
medications become available which are cheaper or more effective, or changes to standards 
of care or the structure of the NHS affecting diabetes outcomes. Guidance for 
recommendations to care continue to evolve: the American Diabetes Association [ADA] 
updated their guidance this year (American Diabetes Association, 2014), and the National 
Institute for Health and Care Excellence [NICE] is reviewing clinical guidance for UK practice, 
to be published in 2015 (NICE, 2014). 
 
Diabesity 
‘Diabesity’ as a term to define the co-occurrence of T2DM and obesity has been used in 
scientific literature since the 1970s (Colagiuri, 2010) and 1980s (Bierman, 1983). It has even 
been proposed that T2DM be renamed ‘obesity dependent diabetes mellitus’ (Astrup & Finer, 
2000) because of the close link between the aetiologies. 
It has been discussed that obese patients with T2DM may traditionally have been given 
inadequate treatment options considering both conditions concurrently: obese patients at 
risk of diabetes may be screened for diabetes infrequently, and once diagnosis has been made 
pharmacological options may favour weight gain in already obese patients  (Haslam, 2010). 
Some pharmacological choices can favour weight loss; a weight loss of 0.6kg to 3.5kg is 
anticipated using metformin, and 1.8 to 6.0kg using GLP-1 (glucagon-like receptor peptide-1) 
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receptor agonists. However sulphonylureas, insulin, TDZs (thiazolidinediones) and 
meglitinides all favour weight gain – up to 5.0kg, 4.0kg and 1.8kg respectively (Lau & Teoh, 
2013). 
Trends in treatment choice have changed over time. Between 1996 and 2005 the proportion 
of those with T2DM on insulin remained stable, the proportion of those on sulphonylureas 
decreased dramatically with a comparable increase in metformin and TDZ use (Gonzalez, 
Johansson, Wallandar & Rodriguez, 2009). Reasons for the changing trends are unknown, 
although drug costs, increased understanding and knowledge, or guideline priorities may be 
contributory factors. Treatment priorities for diabetes may also be affected by Quality 
Outcome Framework [QOF], as General Practitioners are financially incentivised to monitor 
and manage HbA1c closely, but do not have the same motivation to consider their patients’ 
obesity to the same degree (NHS Employers, 2014). 
The nature of T2DM is that it is progressive as pancreatic β-cell function decreases (Kahn, 
Cooper, & Del Prato, 2014). Therefore, in order to maintain glycaemic control over time, an 
increased amount and types of medication may be required (Colagiuri, 2010), increasing the 
likelihood of weight gain. 
In addition, patients may not always have an understanding of the weight management 
challenges posed by some of the antidiabetic medications, or the importance of weight 
management in T2DM treatment – and in one US based study of patients’ perception of their 
T2DM management found that weight management advice is followed most often when 
clinicians raise it as an issue consistently at appointments with specific points of advice 
(Polonsky, Fisher & Hessler, 2010). It also found that even in very obese patients, some 
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reported that their diabetes clinicians had never raised the issue of weight management with 
them. 
 
Dietary management of obesity and type 2 diabetes 
It has been established for many years that people who are obese can improve health risks 
such as blood pressure, glycaemic control and lipid profile by losses of 10% starting body 
weight (Goldstein, 1992). However in studies of T2DM patients, weight losses of just 3% can 
incur meaningful benefit to these factors (Lau & Teoh, 2013) so long as this loss is maintained. 
Current guidance in the UK suggests patients should aim for 5 to 10% (NICE, 2009) concurrent 
to US guidance recommending 7% (Lau & Teoh, 2013). 
However it has been observed that people with T2DM can find weight loss harder than those 
without (Norris et al., 2005), which is thought to be a dual effect of hyperinsulinaemia and 
hypoglycaemia. Insulin resistance leading to elevated insulin levels acts to inhibit lipolysis and 
therefore favouring fat storage. In addition hypoglycaemia incurred through the use of some 
medications can lead to unplanned food intake (Lau & Teoh, 2013). 
UK guidance on weight loss in people who are overweight or obese recommends dietary 
intervention, behavioural change and physical activity as integral to any input (NICE, 2006). 
Dietary guidance for T2DM is healthy eating with a focus on balance across the food groups 
and reduction in salt, fat and sugar (Diabetes UK, 2012a; NICE, 2009). For weight loss, creating 
an energy deficit is recognised as being more important than macronutrient composition, in 
part due to the limited high quality evidence (Diabetes UK, 2011; Nield et al., 2007). 
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However, it has been noted that for people with complex conditions such as T2DM, multiple 
demands on the patients already exist, such as attending regular appointments, taking blood 
glucose readings, administering medications. Although encouraging multiple behaviour 
changes across diet, lifestyle, and physical activity is more effective than individual strategies 
for sustaining T2DM, research has shown that patients comply with achieving single 
behaviours more ably than an integrated approach (Wing et al., 2001). 
Innovative dietary strategies have been proposed for T2DM management, and research into 
ways of achieving optimum weight loss and glycaemic and lipid control is ongoing. 
Low fat diets 
The Look AHEAD (Action for Health in Diabetes) trial (Wing et al., 2010) implemented all three 
recommended aspects of diet, physical activity and behavioural change in their intervention 
group, compared to the control group receiving standard treatment. This US-based 
randomised control trial included 5145 overweight or obese adults with T2DM between the 
ages of 45 and 75 years old. The intervention was based on individualised calorie restriction 
with fat <30% and protein >15% energy. Participants were given portion controlled plans and 
the option of meal replacement drinks to improve adherence if needed. They were supported 
throughout the four-year period, more intensively during the first year then receiving contact 
every two weeks, including face-to-face sessions and by telephone, and were weighed 
regularly. Compared with the control group who received standard care of three group 
sessions a year, the intervention group had lost significantly more weight after four years 
(mean 6.15% loss compared to 0.88% loss, p<0.001), and also showed significant reduction in 
HbA1C (p<0.001) and trends towards improvement in blood pressure (p<0.001 systolic, p=0.1 
diastolic). These effects were not linear: weight loss, increased fitness and decreased HbA1C 
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was most marked at the end of the first year’s more intensive phase, before rebounding 
slightly. 
Other research has been on a much smaller scale. One six-week study of only 11 participants 
found that even ad libitum, low fat (<20% energy) diets could induce weight loss in the short 
term (6 weeks) without detrimental effect to lipid profile or glucose level (Gerhard et al., 
2004). Another 40-week study randomised 79 people with T2DM who were overweight or 
obese into following diets focusing on low-fat (<30% energy) or low-glycaemic index. Both 
groups were calorie-restricted and involved exercise input and behavioural intervention 
(Fabricatore et al., 2011). Both groups lost weight: 4.5% and 6.4% starting body weight 
respectively. However, the difference lost between the groups was not significant (p=0.28), 
suggesting both as successful weight loss strategies. 
 High protein, lower carbohydrate diets 
High protein diets are known to have short-term success in promoting weight loss in the 
general population (Clifton, Condo & Keogh, 2014). The New Zealand based DEWL (Diabetes 
Excess Weight Loss) trial compared a higher protein, lower carbohydrate diet with the higher 
carbohydrate diet in line with current guidelines, in 419 overweight or obese participants with 
T2DM (Krebs et al., 2012). In both groups, patients were assigned individualised calorie 
restricted plans based on 500 calorie deficit/day, and were supported by regular group 
sessions over the first year, which incorporated regular weighing and behavioural change 
input. 
Over the two years, the high-protein and high-carbohydrate groups both lost weight, (mean 
3.8% and 5.9% of original body weight respectively), and saw similar attrition rates (30.4% 
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and 28.9% of original cohort), indicating similar acceptability levels of conforming to the 
dietary requirements of the study. The energy balance of the high-protein diet was designed 
to be 30% protein, 40% carbohydrate and 30% fat, and the high-carbohydrate diet 15% 
protein, 55% carbohydrate and 30% fat. However by the 24-month point both groups had 
tended towards a mean diet similar to the reported baseline nutrient balance rather than the 
prescribed balance. The authors comment that this may reflect wider difficulties in sustaining 
dietary change. 
Dietary compliance may also be confounded through the self-reported diet diaries which 
were used to assess nutrient balance. Underreporting in food diaries is common, in particular 
in those who are obese (Kretsch, Fong & Green, 1999). Notwithstanding this, both groups 
succeeded in long-term weight loss, and both groups experienced a similar degree of attrition. 
It is possible that the common factors including dietary advice, regular input and weighing 
may have contributed to the success of both groups, irrespective of intended dietary balance. 
It may also be a contributing factor to the success of the intensively treated group in the Look 
AHEAD study compared to the control group. A review of higher protein, lower carbohydrate 
diets concluded that the long term weight loss outcomes compared to the conventional 
healthy approach are similar (Dyson, 2014). 
The findings of the DEWL study concur with the findings of a smaller US-based 12 month 
study, which randomised 105 participants into high-protein (20-25g carbohydrate) or low-fat 
(<25% energy) diets (Davis et al., 2009). Similarly, both groups lost similar amounts of weight 
by the twelve-month point (mean 3.1kg in both groups), and saw comparable rates of attrition 
(overall attrition 19%, arms reported to have ‘similar’ attrition, not specifically noted). This 
study also noted a lapse from the prescribed macronutrient balance. The authors discuss the 
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racial and cultural variation within their study groups, and suggest that the high number of 
black and Hispanic participants (which combined made up 80% of the cohort) may have found 
the macronutrient balances harder to achieve compared to the composition of their usual 
diets.  
Neither DEWL nor the smaller US study saw any notable decreases in HbA1c. However, Davis 
et al (2009) specifically reported reductions of antidiabetic medication in anticipation of 
decreased needs according to the assigned dietary arm, which may have impacted on 
glycaemic control and masked any benefit to HbA1C. DEWL did not report whether any 
changes to medications were made. In contrast, a meta-analysis of older, smaller, shorter-
term studies comparing low carbohydrate diets with higher-carbohydrate found that 
decreases in HbA1C were linked (p=0.013) with lower proportion of carbohydrate (Kirk et al., 
2008). The meta analysis discussion acknowledges that weight loss itself can reduce HbA1C as 
an additional confounding factor.  
The American Diabetes Association (2013) notes the recommended requirement of 
carbohydrate is a minimum of 130g/day to supply the nervous system, and the tendency of 
carbohydrate-rich foods in also containing necessary vitamins and minerals. 
Meal replacement diets 
Meal replacement diets are often used to form very low calorie diets (VLCDs), which NICE 
defines as <1000 calories/day (NICE, 2006). A 2005 Cochrane review of weight loss 
interventions in T2DM found VLCD a successful strategy as part of multifaceted approach 
(Norris et al., 2005). More recently, in very small scale non-randomised studies, VLCD meal 
replacement programmes have shown effective in short-term diabetes management. In UK 
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research of a small sample of 11 subjects, rigorous dietary restriction over an 8-week study 
period demonstrated normalisation of glycaemic control in all patients, compared to a non-
T2DM control group of similar anthropometry. The subjects consumed meal replacement 
drinks, supplemented with vegetables to the combined value of 600 calories (Lim et al., 2011). 
The cohort were overweight or obese at start (mean 33.5 kg/m2), weight loss over the 8 week 
study period was mean 15.3kg (15% mean starting body weight). Fasting glucose of the 
diabetes cohort had become not significantly different to the non-diabetes cohort within the 
first week of the diet (p=0.18), and HbA1c had decreased to become not significantly different 
to the non-diabetes cohort by the eighth week (p=0.27). 
The diabetes cohort was provided with information about healthy eating and portion control 
to support them post-research, and twelve weeks after the end of the study, three of the 
eleven participants had returned to being classified as having diabetes. Mean weight gain was 
3.1kg, and mean fasting glucose had significantly risen since the endpoint (p<0.01). No longer 
term follow-up assessed the effectiveness as a sustainable strategy for diabetes treatment. 
Furthermore, all the participants had been diagnosed less than 4 years prior to the study, and 
were either treated by diet alone or by metformin or sulphonylureas. These medications were 
stopped prior to the commencement of dietary restriction, to avoid confounding the results, 
and it is not reported whether these required recommencement in the months following the 
trial. 
This study was followed by another equally small British study (Hookey, O’Shea, Freeman & 
Collins, 2014) which added a psychological component to an eight-week meal replacement 
diet, consisting of 600 calories from meal replacement drinks and 200 calories from additional 
vegetables. Again all subjects had been diagnosed with diabetes within the 4 years previously, 
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and were all obese (mean BMI 38.4 kg/m2). Psychological input occurred in five group sessions 
per week for the first two weeks, and subsequently twice a week for six weeks. This study also 
looked at outcomes 3 and 12 months after the start of the study. 
Mean weight loss over the 8 weeks was 16.6kg (14.7% mean starting weight). Significant 
decreases to HbA1C, cholesterol, and glucose level were seen at the end of the intervention 
(p<0.001, p<0.0001, and p<0.002 respectively), but by the three months point only HbA1C was 
significantly different to starting level (p<0.002), and this effect was not seen by 12 months. 
However, the weight loss was better sustained – a mean of 2.0kg regained by the three month 
mark. Drop out by 12 months was high (only 4 of the original 11 participants remained), but 
mean loss at that point was 9.3kg. The authors of this study note that comparison with the 
original 2011 study is limited because of its lack of published follow-up, and because of its 
own high drop-out rate at 12 months. Therefore the benefit of the additional psychological 
input is unclear quantifiably. In feedback questionnaires, however, participants reported 
finding this element useful, both for the peer support of the groups and the psychological 
strategies. 
Intermittent fasting 
Intermittent fasting (restricting calories on some days of the week and eating ad libitum for 
the remainder) as a weight-loss method has become a popular strategy in the general 
population. Compared to moderate daily calorie restriction, intermittent fasting has been 
shown in a review of studies comparing both (Varady, 2011) to be as effective at weight loss, 
and may confer an advantage in preserving fat free mass during weight loss. Research 
involving those at high risk of developing diabetes indicate that intermittent fasting may be 
of benefit in preventing the onset of diabetes (Barnosky, Hoddy, Unterman & Varady, 2014). 
pg. 16 
J03678 Research Project 
 
The use of intermittent fasting in those who have developed diabetes is proposed as an area 
for future investigation (Brown, Mosley & Aldred, 2013). Public health guidance cautions 
those with diabetes from undertaking intermittent fasting (NHS Choices, 2013), especially 
those taking insulin (Patient UK, 2014). Longer-term studies into the efficacy of intermittent 
fasting has not been explored (Dyson, 2014). 
Qualitative changes to diet 
There is also a strong body of evidence that qualitative dietary changes independent of weight 
loss are also beneficial to management of T2DM (Annuzzi, Rivellese, Bozzetto, & Riccardi, 
2014). Reduction in saturated fatty acids and an increase in monounsaturated fatty acids, a 
decrease in salt intake, and a focus on consumption on low glycaemic index, have all been 
found across studies to improve the health markers of insulin resistance, hypertension, and 
dyslipidemia. The reviewers suggest that qualitative changes may be more sustainable than 
maintaining weight loss, although they provide no evidence to support this claim.  
 
Bariatric surgery 
Bariatric surgery as a weight loss treatment option also improves glycaemic control in 
diabetes, in addition to promoting and maintaining higher levels of weight loss than dietary 
or pharmacological treatments can offer (Lau & Teoh, 2013). Both weight loss expectation 
and degree of diabetes remission varies by procedure and length of time since the diabetes 
diagnosis (Dixon, Zimmet, Alberti & Rubino, 2011). Bilio-pancreatic diversion can be expected 
to induce 73% excess weight loss, with 95% of diabetes in remission after two years. The roux-
en-Y bypass and gastric band typically results in 63% and 49% of excess weight loss 
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respectively, and remission of 80% and 57% diabetes at two years respectively (Dixon, 
Zimmet, Alberti & Rubino, 2011). 
Although diabetes remission is thought in the long-term to be a primarily a consequence of 
weight loss, early improvements in glycaemic control prior to substantial weight loss 
occurring is seen more in diversionary procedures, hypothesised to be related to changes to 
gut hormones (Dixon, Zimmet, Alberti & Rubino, 2011). Two primary theories have been 
proposed: the first suggests that as food reaches the small intestine more quickly during 
digestion, in turn increasing the release of glucagon-like- peptide-1 (GLP-1) into the gut 
(Mingrone & Castagneto-Gissey, 2009), this then stimulates insulin secretion and removes 
glucose from the bloodstream (Rubino, 2008). The second suggests that diversion of food 
away from the upper part of the small intestine results in decreased release of anti-incretin 
hormones (which blunt the insulin response), thereby improving glycaemic control (Mingrone 
& Castagneto-Gissey, 2009). It is thought that the former is more likely, as little is known 
about anti-incretin hormones (Rubino, 2008). 
A US retrospective cohort study of gastric bypass patients found that of the 4434 with 
diabetes who underwent surgery, 68.2% experienced initial remission, of which 35.1% saw 
re-emergence of diabetes within 5 years (Arterburn et al., 2013). However, it is recognised 
that long-term follow-up of bariatric patients across all procedures is currently limited (Lau & 
Teoh, 2013), including the lifelong nature of bariatric surgery on diabetes reoccurrence. 
Bariatric surgery may also aid improvement to microvascular complications, although the 
evidence is limited (Neff & le Roux, 2013). Any benefit to diabetic nephropathy following 
surgery is unknown and it is suggested that it would be confounded by the potential onset of 
nephropathy due to micronutrient deficiency, which can occur after bariatric surgery due to 
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high alcohol consumption or non-compliance with micronutrient supplementation. A review 
of the available evidence suggests that retinopathy improves following bariatric surgery, and 
can help to delay onset in those at risk, although specific control trials to quantitatively assess 
the role of surgery in retinopathy are needed. For those with moderate kidney disease, 
function can be maintained or improved by surgery. Those with more severe nephropathy are 
often precluded from bariatric surgery because of the perceived surgical risks, although it is 
thought that the surgery may in fact improve renal function. 
Despite the limited long-term follow-up, guidelines are currently being drafted 
recommending bariatric surgery as a treatment option for those diagnosed with T2DM within 
the last 10 years, and a BMI >30 kg/m2, or lower in those of Asian origin. This compares with 
current guidance advising that surgery be considered as an option for those with T2DM and 
a BMI >35 kg/m2 (NICE, 2014a). There are additional considerations to bariatric surgery: the 
provision of specialist surgical facilities, psychological readiness to adapt to post-operative 
dietary restrictions, ability to attend multiple and long-term follow-up, and the risk of needing 
revisional procedures at a later stage (NICE, 2006). 
Guidance is not necessarily implemented at local level, however the change in guidelines may 
in part reflect the increased understanding of the benefits of bariatric surgery in diabetes 
treatment. 
 
Multifaceted diabesity services 
In response to the comorbid rise of diabetes with obesity, multidisciplinary diabesity services 
have in some places been piloted, for those with or at risk of developing T2DM. The Mid 
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Yorkshire NHS Trust has developed an approach which seeks to improve obesity and diabetes 
outcomes together. The team includes a consultant, diabetes specialist nurse, psychologist, 
dietitian, physiotherapist and occupational therapist (Rajeswaran, Pardeshi, & Srinivasan, 
2012). The dietitian, psychologist, physiotherapist and occupational therapist are able to 
implement the dietetic, behaviour change and physical activity aspects of improved 
management, with the consultant and diabetes specialist nurse focusing on pharmacological 
considerations, blood test results and any other comorbidities, such as sleep apnoea or 
hypogonadism. 
The twelve-week group programme piloted by Mid Yorkshire NHS Trust shows successful 
short-term outcomes. Retention rate amongst the 143 adults was 90%. Mean weight loss was 
3.6% in the 12-weeks, and up to 40% of the participants who had enrolled on the programme 
with a view to bariatric surgery had changed their mind about being considered (Srinivasan, 
2014). The dietetic strategies employed on the programme were not reported. However, as 
previously discussed the support and regular input surrounding the dietetic care may have 
contributed as influentially as the dietary guidance. 
The retention rate of 90% compares favourably with other standard weight management 
programmes. In a review of 25 studies reporting weight management service outcomes, 
between 13.4% and 80% attrition was observed (Miller & Brennan, 2014), although what was 
defined as ‘attrition’ varied between studies: in some studies it was attending fewer than a 
set proportion of appointments, whereas in others it referred to those who failed to attend 
by the end-point. It has been suggested that poor early weight loss may increase risk of 
consequent drop-out in weight management services (Miller & Brennan, 2014). Patients in 
the Mid Yorkshire programme received intensive and regular input (Srinivasan, 2014), 
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enabling the team to identify those at risk of reduced weight loss, and possibly minimise 
attrition. 
In addition, the programme focuses strongly on self-management (Rajeswaran, Pardeshi, & 
Srinivasan, 2012). In a US survey of overweight and obese T2DM patients, weight loss was 
more successful in those with greater understanding of the role of weight management in 
their T2DM control (Polonsky, Fisher & Hessler, 2010). 
The benefit of lifestyle modification programmes as a lifetime strategy for diabesity has been 
disputed, with long-term weight regain and consequent decreased glycaemic control often 
occurring (Colagiuri, 2010). The Mid Yorkshire pilot does not report whether they will be 
following up their participants long-term, but did invite completers to return after a year for 
further input if necessary (Srinivasan, 2014). 
 
Conclusion  
Both bariatric surgery and multifaceted diabesity services offer promising solutions for the 
increasing burden of diabesity in the UK. However, this literature review has also seen that 
there are other opportunities, and challenges to be met, in tackling diabesity in the UK and 
internationally. 
The increasing research into innovative pharmacotherapies for diabesity management 
recognises the need to control glucose levels without the side effects of weight gain or risk of 
hypoglycaemia (Verspohl, 2012), potentially decreasing the challenges of weight loss for the 
future. In addition, a larger scale UK-based study utilising meal replacement VLCDs in T2DM 
has been funded to build on the preliminary trials discussed, using a larger cohort in the real-
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life setting, and comparing with currently available standard diabetes management (Diabetes 
UK, 2014). 
Emphasising to patients the central importance of weight management as treatment for 
T2DM may influence motivation to persevere at weight loss (Polonsky, Fisher & Hessler, 
2010). In addition, trial conditions may not reflect applicability to real life settings, and the 
facilities and service provision are unlikely to be practicable at local level. Studies comparing 
dietary balance observed that the regular input and support may be of as much benefit to 
weight loss as optimising dietary input specifically to T2DM (Krebs et al., 2012; Davies et al., 
2009). Therefore, in the absence of multifaceted diabesity services, it is feasible to suggest 
that a local specialist weight management service may be able to benefit T2DM patients. 
Yet in light of the current challenges to weight loss discussed in this review (Lau & Teoh, 2013; 
Haslam, 2010), it is unclear how outcomes for those with T2DM compare with non-T2DM 
counterparts receiving the same pathway of care. In light of the rising costs of diabesity (Zhou, 
Zhang & Hoerger, 2013; Hex, Bartlett, Wright, Taylor & Varley, 2012), assessing the 
effectiveness of existing locally available services in T2DM management may provide valuable 
insight in establishing what complementary service provision is required. 
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Differences in outcomes between type 2 diabetes and non-type 2 diabetes patients in a 
local specialist weight management service 
Rationale for journal choice: Journal of Human Nutrition and Dietetics 
Journal of Human Nutrition and Dietetics is a peer-reviewed journal publishing work in the 
area of dietetic practice. As it is the journal of the British Dietetic Association, the subject 
matter will be relevant to many of the primary readership working in similar clinical settings. 
It is also likely to attract readers of other professions of the multidisciplinary team, such as 
GPs, diabetes specialist nurses, diabetologists and practice nurses who are seeking evidence 
around the role and effects of dietetic intervention. 
Abstract  
Background: Being overweight or obese is known to increase risk of type 2 diabetes (T2DM), 
and as obesity levels have risen nationally, levels of T2DM have also increased. Conversely 
weight loss has long been recognised as an effective strategy for improving management of 
T2DM, although it is acknowledged that weight loss in T2DM may be slower. It is 
recommended that obese people with T2DM are provided with appropriate support. In a local 
dietetics department this is via a Specialist Weight Management service.  
Study Aim: To compare outcomes between patients referred to the service with a diagnosis 
of T2DM compared to those without, and outcomes of those with T2DM by treatment type. 
Methods: Data from NHS Trust care records from 231 patients referred into the service over 
a six month period was used to evaluate weight loss in those with and without a diagnosis of 
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T2DM. Changes in food frequency scores and metabolic output were also compared. Of those 
with T2DM, patients were grouped by pharmacological treatment type to compare outcome. 
Results: There were no significant differences between the two groups at the starting point, 
with regard to mean weight or BMI, or reported food frequency score or metabolic score. 
Both groups showed significant mean weight loss, and there was no significant difference 
between the two groups. Significant improvements to reported food frequency and metabolic 
output scores were seen in the non-T2DM group, but not the T2DM group. However, high 
attrition was seen in both groups, therefore the pharmacology subgroups were small and 
statistical analysis was not viable. 
Conclusion: A local dietetic weight management service can successfully effect weight loss as 
part of the management of obese T2DM patients. 
Key words: type 2 diabetes, obesity, weight management, dietary intervention  
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Introduction 
Clinical Background 
Type 2 diabetes (T2DM) is on the rise in Britain (Diabetes UK, 2012), primarily as a result of 
increased obesity rates (Abdullah, Peeters, de Courten & Stoelwinder, 2010). T2DM can have 
considerable impact on health including cardiovascular complications and decreased life 
expectancy (Lau & Teoh, 2013). Lifelong management of diabetes is expensive (Zhou, Zhang 
& Hoerger, 2013), although modest sustained weight loss in those carrying excess weight can 
improve diabetes control (Lau & Teoh, 2013). Diabetes patients are often referred to weight 
management services, however weight loss in those with diabetes is often found to be slower 
than in their counterparts without diabetes (Lau & Teoh, 2013; Norris et al., 2005). 
In part this is thought to be due to the challenges posed by diabetic medication, some of 
which favour weight gain (Haslam, 2010). This can be compounded over time as the disease 
progresses (Kahn, Cooper, & Del Prato, 2014), increasing likelihood of needing more types of 
medication (Colagiuri, 2010) in order to maintain control. 
 
Review Question 
This study compared outcomes between patients with a diagnosis of T2DM and those 
without, who participated in a local specialist weight management service. The outcomes 
considered were: 
 Change in weight, and consequently to body mass index (BMI) 
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 Changes in reported metabolic output 
 Changes in food frequency questionnaire score 
Among those diagnosed with T2DM, comparisons were further made in outcomes according 
to treatment category. 
Context 
The dietetic department at Warrington and Halton Hospitals NHS Trust is provides a specialist 
weight management service to obese patients living in the Halton area, including those with 
complex medical conditions, and those wishing to be considered for bariatric surgery. The 
service offers dietetic support to patients at regular intervals for up to two years. In addition, 
patients requiring specific support can access specialist cognitive behavioural therapy via 
referral from the dietitian. Patients may also attend a group programme of nutrition 
education and exercise, which is open to all overweight adults who are fit enough to 
participate in the exercise session. 
Patients attending the weight management programme are formally assessed at their initial 
appointment, and again after 6, 12, 18 and 24 months. The assessed outcomes include 
physiological measures of weight and BMI changes, and lifestyle measures of reported food 
frequency questionnaire and metabolic output reported scores (APPENDICES A&B). 
It is known that weight loss efforts transition towards weight maintenance after six to nine 
months after commencing weight loss treatment (NICE, 2006). Therefore this review will 
focus on outcomes occurring during the first six months of treatment within the specialist 
weight management service. 
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Methods  
Participants All patients referred to the Specialist Weight Management service between 1st 
June 2013 and 31st December 2013 were considered for inclusion. Their data was accessed 
through the department’s database, DWARF. Participants are detailed in Figure 1. 
Pregnant patients were excluded because of the confounding effect of pregnancy on weight. 
Any patient who did not have a diagnosis of T2DM at their initial assessment but went on to 
develop it within the 6 months was grouped with those without a diagnosis of T2DM.  
Consent was granted by Warrington and Halton NHS Trust to use the data in anonymised 
format for the purposes of this service review (APPENDIX C). The proposed evaluation was 
given ethical approval by the University of Chester Ethics Committee before it was conducted 
(APPENDIX D).  
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Figure 1: participant inclusion process 
Research Design The study used a retrospective cohort design. Patients were only selected 
for the service review based on the date on which they were referred into the Specialist 
Weight Management service, no other inclusion criteria were applied. All data had already 
been collected; no intervention was specifically implemented on this cohort of patients aside 
from standard care provision. 
Measurement procedures Data for each patient was collected from the paper documentation 
recorded at the time of each point of contact, and transferred anonymously to SPSS version 
21.0. Height was recorded to the nearest centimetre from GP records or as assessed by health 
trainer – and was assumed to remain constant over the duration of the intervention. Weight 
was read to the nearest 0.1kg on calibrated scales at each dietetic appointment, with patients 
wearing light clothes. Food frequency and metabolic output were self-reported by 
ALL REFERRALS: 231 
231 patients referred into the 
service between 1 June 2013 and 31 
December 2013 
EXCLUSIONS: 63 
 56 declined to accept referral 
 5 medically inappropriate 
 2 pregnant at time of referral 
 7 known to have diagnosis T2DM 
(11.1%) 
PARTICIPANTS RECEIVING INPUT: 
168 
 43 diagnosed T2DM (25.6%) 
 125 no diagnosis 
PARTICIPANTS AFTER 6M: 73 
 18 diagnosed T2DM (24.7%) 
 55 no diagnosis 
ATTRITION: 95 
 25 diagnosed T2DM (26.3%) 
 70 no diagnosis  
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participants who were asked questions verbally by the dietitian during the relevant 
appointments (APPENDICES A&B). Diagnosis of T2DM, and medications, were detailed on the 
referral documentation, or self-reported by the patient and noted on the care record 
(APPENDIX E). 
Those with T2DM were categorised further into: no diabetes medication (treating with diet 
and lifestyle only); those on monotherapy; those on multiple medications but not insulin; and 
those on multiple medications including insulin. 
Data analysis 
Data was input in anonymised format to a Microsoft Excel spreadsheet. Those who dropped 
out were then removed from the spreadsheet, and further basic analysis used to calculate 
changes in outcome measures (weight, BMI, food frequency score and metabolic equivalent) 
on the remaining subjects. At this stage information was transferred to SPSS version 21.0 for 
comparative statistical analysis between the diabetes and non-diabetes groups. 
Comparing between T2DM and non-T2DM groups, the distributions did not meet the Shapiro-
Wilk statistic for normality (either or both groups showed p<0.05 in all comparisons). 
Therefore a Mann-Whitney U test was conducted for each.  
Comparing between T2DM and non-T2DM groups, the distribution for starting FFQ score and 
changes to FFQ score met conditions for normality and homogeneity of variance, and an 
independent t-test was conducted for each. 
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The distributions for starting metabolic output score, and changes to metabolic output score, 
did not meet the Shapiro-Wilk for normality (one or both groups showing p<0.05). Therefore 
a Mann-Whitney U test was conducted for each. 
The significance of changes to weight, food frequency score and metabolic output score was 
assessed for both T2DM and non-T2DM groups. Weight changes in both groups did not meet 
the Shapiro-Wilk statistic for normality (either or both groups showed p<0.05) and a Wilcoxon 
test was conducted. Likewise, metabolic output score changes in both groups did not meet 
the Shapiro-Wilk statistic for normality (either or both groups showed p<0.05) and a Wilcoxon 
test was conducted for both T2DM and non-T2DM subgroups. 
Food frequency score chances in both groups met conditions for normality (both groups 
showed p>0.05) and a paired t-test was conducted for both T2DM and non-T2DM subgroups. 
Results are presented as: Mean (Standard Error). Statistical significance is accepting at p<0.05. 
Results   
Of patients who were seen for at least one appointment, mean starting BMI was 39.2 kg/m2; 
78.5% female, 21.5% male. 
Physiological outcomes 
The comparison between physiological outcomes are shown in Table 2 
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Table 2: Comparison of physiological outcomes between diabetes and non-diabetes groups 
over six months 
 T2DM (n=18) No T2DM (n=55) P 
Starting weight (kg) 120.11 (8.38) 112.73 (3.48) 0.586 
Weight change (kg) -4.26 (1.27) -3.76 (0.92) 0.582 
Starting BMI (kg/m2) 42.97 (2.57) 41.31 (1.10) 0.888 
BMI change (kg/m2) -1.51 (0.49) -1.41 (0.33) 0.683 
Lifestyle outcomes 
The comparison between lifestyle outcomes are shown in Table 3. 
Table 3: Comparison of lifestyle outcomes between diabetes and non-diabetes groups over six 
months 
 T2DM (n=18) No T2DM (n=55) P 
Starting FFQ score 27.3 (1.61) 25.6 (0.83) 0.331 
Change to FFQ score 3.53* (1.89) 3.86^ (0.77) 0.846 
Starting metabolic 
output 
521.9 (275.5) 553.3 (136.9) 0.354 
Change to metabolic 
output 
29.9* (239.6) 489.8§ (126.2) 0.115 
*n=17, ^n=51, §n=52 
 
Comparison between pharmacotherapy treatment amongst the diabetes group 
Only 18 patients with diabetes received treatment to six months, distribution shown in Table 
4.  
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Table 4: distribution of T2DM patients by pharmacotherapy treatment 
 
Number 
of patients 
Mean start 
weight (kg) 
Mean weight 
change (kg) 
Mean start BMI 
(42.3kg/m2) 
Diet only 3 129.1 -5.8 42.3 
Monotherapy 8 121.0 -4.8 46.1 
Multiple therapies (not 
including insulin) 
5 116.9 -4.8 39.2 
Multiple therapies 
including insulin 
2 111.3 1.6 40.7 
Because of the small subgroup size, an ANOVA to compare the groups statistically was not 
possible, although the descriptive statistics suggest that treatment involving more 
medications may be linked with less weight loss. 
Table 5: statistical significance between starting and six-month data 
  Start 6M change P 
T2DM 
(n=18) 
Weight (kg) 120.11 (8.38) 115.9 (8.14) -4.26 (1.27) 0.007 
FFQ 27.3 (1.61) 30.2 (1.15) 3.53* (1.89) 0.08 
Mets 521.9 (275.5) 522.8 (150.1) -29.9* (239.6) 0.463 
No T2DM 
(n=55) 
Weight (kg) 112.73 (3.48) 109.0 (3.76) -3.76 (0.92) 0.0001 
FFQ 25.6 (0.83) 29.5 (0.80) 3.86^ (0.77) 0.0001 
Mets 553.3 (136.9) 1073.6 (162.5) 489.8§ (126.2) 0.0001 
*n=17, ^n=51, §n=52. FFQ= food frequency questionnaire score, Mets = metabolic output score 
 
Discussion  
Outcomes of the service in general 
Both T2DM and non-T2DM groups lost a significant amount of weight. Other studies have 
found comparable weight loss. A similar NHS-funded programme in Shropshire evaluated 
weight loss in 1129 participants, and found that men and women lost mean of 5.7 and 4.2kg 
over twelve weeks (Bhogal & Langford, 2014). They observe that the men may have lost more 
due to having a higher starting body weight (mean 113.4kg compared to 94.9kg women). The 
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authors do not comment whether the weight loss between the two genders is significantly 
different; in this study although there was no statistical difference between the amount of 
weight lost between the groups, T2DM group had a slightly higher starting mean weight, and 
a slightly greater mean weight loss. However decreases in BMI were not statistically different 
between the two groups. 
At the start point, metabolic output was not significantly different between the two groups 
(Table 3). However, metabolic output increased significantly in the non-T2DM group over the 
six months, but not in the T2DM group (Table 5). Regular physical activity is recommended to 
improve health markers as well as improve weight loss (Myers, 2003). In addition, evidence 
from people who have successfully maintained weight loss report that the majority increased 
their physical activity whilst losing weight, and still undertake daily physical activity (National 
Weight Control Registry, n.d.). 
Likewise, starting food frequency score was not significantly different between the two 
groups (Table 3), and the increase in the non-T2DM group was significant after six months, 
compared to a non-significant change in the T2DM group (Table 5). The questionnaire used 
was designed specifically for this weight management service, and is therefore not directly 
comparable with other studies. However the key aspects demonstrated by the food 
frequency questionnaire of regular and balanced eating are considered the primary steps in 
recommended dietetic practice (Grace, 2011). 
The gender balance (78.5% female, 21.5% male) of attending participants in this study is seen 
elsewhere. The Shropshire weight management programme observed that their intake 
showed a greater proportion of women than men (71.9% female, 28.1% male) (Bhogal & 
Langford, 2014), although both men and women lost weight and sustained their losses. Even 
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in the male-oriented environment of US military veterans, women are disproportionately 
represented in their weight management programme: only 5.5% of military veterans are 
female, but 14% of the 18, 865 participants were female (Spring et al., 2014). It is not 
discussed whether this is because these females are disproportionately aware of the 
importance of weight management, or because females are disproportionately likely to be 
overweight than their male counterparts. 
It is also not known whether patients were attending for support for the first time, or whether 
they had attended the Specialist Weight Management service previously. It has been 
observed that repeated intervention is likely to be of benefit to those who are obese (Spring 
et al., 2014). Locally, policy allows for patients to be re-referred to the Specialist Weight 
Management service after their two-year discharge point. However, as repeat patients may 
be seeking support with weight maintenance rather than weight loss, this may not accurately 
reflect overall weight loss, and these patients may be more likely to maintain lifestyle and 
activity behaviours, rather than seek to improve them further. 
T2DM compared with non-T2DM 
Despite the expectation that T2DM creates challenges to weight loss (Lau & Teoh, 2013), 
weight loss in the T2DM group was not statistically different to the non-T2DM group. 
However, improvements in reported food frequency scores and metabolic output were 
significant in the non-T2DM group compared to T2DM, which may be of relevance to longer-
term outcomes. It is known that in encouraging behaviour change in other medical conditions, 
attempting engagement of multiple behaviour changes is less effective than focusing on one 
at a time. This may also hold true in T2DM, and depend on motivation behind wanting to 
engage in behaviours (Wing et al., 2001). For example, perceived risks of hypoglycaemia after 
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engaging physical activity, or from instigating a reduction in calories through carbohydrates, 
could be considered by the patient to outweigh the benefits in weight management, and limit 
their willingness to change in these areas. 
Of those who received treatment in this service, 25.6% had a diagnosis of T2DM. This is above 
population average, but is anticipated given that obesity is the primary risk factor for onset 
of T2DM (Diabetes UK, 2012). In the area served by the weight management service, 7.2% of 
the local population (7,367) are known to have a diagnosis of diabetes (Public Health England, 
2014). In previous years this locality has mirrored wider trends, with 90% of diabetes 
diagnoses being T2DM (NHS Information Centre, 2010). It is anticipated that this under-
represents the total number of those with type 2 diabetes due to those who are undiagnosed 
(NHS Information Centre, 2010). 
However, of the local T2DM population, the service is supporting a small proportion. Some 
T2DM patients may have declined input, be receiving weight loss support from a commercial 
provider or via the diabetes dietitian. Until recently, local patients were referred to the 
diabetes dietitian at initial diagnosis of T2DM, (97 referrals were made to the diabetes 
dietitian during January to June 2014) who would provide education and onward referral to 
the weight management service for any patients who were appropriate and accepted the 
referral. However, due to recent pathway changes all obese T2DM patients referred to 
dietetics are now seen by the weight management service as first line treatment. 
Comparing Halton with the national picture, the proportion of T2DM patients receiving the 
full complement of recommended care processes falls in the second quartile, above average. 
In addition, those for whom cholesterol, blood pressure and HbA1C targets are being met fall 
in the first centile, above average (NHS Information Centre, 2010). It is possible that clinicians 
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therefore do not feel the need to address obesity as an issue in patients already achieving 
good management markers, even at higher BMI. 
Pharmacological Subgroups 
No statistical analysis was possible with the small subgroups. A larger cohort would have 
presented the opportunity for further analysis. However, it is interesting to observe the 
spread of patients across the subgroups. Guidelines recommend instigation of 
pharmacotherapy in those for whom diet and lifestyle as first line treatment does not provide 
adequate control (NICE, 2009). Changes to the pathway provision may mean that in future 
more newly diagnosed patients at the ‘diet only’ stage of disease progression are seen by the 
weight management service. 
Limitations 
Several limitations of the study were identified. Primarily, the high attrition rate to the service 
of 56.6% reduced the number of participants whose 6 month data could be included. This 
trend is reported in cohort studies of other weight management services (Bhogal & Langford, 
2014). Attrition rates from weight management services were studied in a large cohort of 
nearly 30,000 overweight and obese individual enrolled to services associated with the US 
military (Spring et al., 2014), who reported high drop-out rates in the early stages of 
intervention. They identified a number of factors associated with attrition rate. They found 
that those most likely to keep attending had a higher starting BMI, had more comorbidities, 
and were older. 
They also found that local resources and facilities made a difference. Those who were offered 
a wider range of strategies (such as goal-setting, structured diet plans, physical activity, self-
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monitoring, behavioural support) achieved a higher retention rate. Measuring these factors 
are outside the scope of this review, however this service is not alone in experiencing attrition 
of participants. The impact of attrition is not only on those who drop out, but affects the 
resources available to the continuing participants, incurs wasted administration costs, and 
limits the value of outcome data and the interpretation which can be drawn from them (Miller 
& Brennan, 2014). 
Reasons for T2DM attrition has also been studied. A review evaluating why people with 
chronic illnesses fail to attend services included several studies of diabetes patients (Paterson, 
Charlton & Richard, 2010). Most consistently poor compliance of diabetes patients was 
related to high HbA1c, high blood pressure and high BMI. But those with fewer complications, 
and lack of perception of severity were also linked with poorer attendance. The authors of 
the review comment that if the clinician does not explain the relevance of their care they may 
not see the importance of coming back. It is also possible that if the referring clinician does 
not explain the reason for their referral, they may not feel the need to attend their first 
appointment. Non-attenders are not routinely followed-up to gain insight into why they 
choose not to continue with care, and up-to-date biochemistry is not always available to 
gauge whether the patient’s efforts are impacting on health markers. However, it recognises 
the role of referring clinicians in emphasising the relevance of the referral and weight 
management in minimising attrition. 
Limitations to the quality of the data also exist given the self-reported nature of the lifestyle 
outcomes: food frequency questionnaire scores are by their nature self-reported, and 
metabolic output was also self-reported. Food frequency questionnaires are known to have 
limited reliability when used as an isolated measure of food intake (Brown, 2006), and 
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although this questionnaire meets the commissioning body’s requirements, it is not a 
validated tool. It is also possible that participants answered with bias, overestimating the 
quality of their lifestyle in order to avoid feeling that they will be judged by the dietitian. 
Diagnoses and medications were in many cases self-reported, with potential for error of 
accuracy. It is also possible that, given the estimates of undiagnosed diabetes prevalence in 
the UK and locally (Shaw, Sicree & Zimmet, 2010; NHS Information Centre, 2010) an additional 
proportion of those considered not to have diabetes could have been diagnosed if tested at 
the time of referral. In addition, non-obesity related medications (commonly anti-psychotics 
and antidepressants) can confound weight loss in both groups (American Diabetes 
Association, American Psychiatric Association, American Association of Clinical 
Endocrinologists, & North American Association for the Study of Obesity, 2004; Patten, 
Williams, Lavorato, Khaled & Bulloch, 2011). 
Recommendations for future research 
Analysis of a larger cohort of patients would allow a more thorough assessment of this 
population. The current service provision has been offered since 2011, for which data is 
available. However, for the T2DM patients historic data may not reflect current practice (for 
example pharmacology pathways, provision of group education, dietary guidelines). With a 
larger cohort it would also be possible to compare outcomes for those who concurrently 
receive specialist weight management with active input from a diabetes professional, with 
those who are not receiving active input. Comparison with outcomes from the diabetes 
dietetic service would also be of benefit to ensure best and effective practice is being shared 
consistently. 
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In addition, in time longer-term (12 and 24 month) outcomes for the current cohort will be 
available, providing further insight into the service’s effectiveness at weight maintenance 
stage as well as during the weight loss time frame. This may also contribute further to 
understanding the differences between lifestyle outcomes between T2DM and non-T2DM 
groups. 
Currently, there are no specific outcome measures tailored to evaluate the impact of the 
weight management service on T2DM in that subgroup. Measures for consideration include 
most recent HbA1C, fasting blood glucose, frequency of experiencing a ‘hypo’, perceived 
understanding and ability to manage T2DM. Comparing these outcomes with weight loss may 
inform whether weight loss and improved T2DM control are both achieved concurrently using 
the approaches available in this service, especially as weight loss appears to occur significantly 
before lifestyle patterns change. It may also serve to demonstrate the effectiveness of the 
service as an integrated part of the diabetes multidisciplinary approach. 
As discussed above, provision of different aspects of weight management can improve 
retention rate (Spring et al., 2014), and some service factors are linked with attrition 
(Paterson, Charlton & Richard, 2010). This service is able to provide a number of aspects 
within the service, including: psychological input, exercise sessions, individualised portion 
plans, consideration for bariatric surgery, although patients may be only accessing those most 
relevant to them. Were a larger cohort available, analysis of retention and weight loss 
outcomes according to which aspects are accessed may be useful in determining where 
funding is most beneficially spent. 
In particular, because bariatric surgery is becoming increasingly accepted as a beneficial 
treatment for diabetes remission prior to weight loss (Dixon, Zimmet, Alberti & Rubino, 2011), 
pg. 49 
J03678 Research Project 
 
it is not known whether the proportion of T2DM patients in this service seeking bariatric 
surgery reflects this, and the potential economic benefits of preparing and funding patients 
to undergo this process have not been evaluated. 
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APPENDIX A: Food Frequency Questionnaire 
 
Name: _____________________________   
 
*Since you started the Fresh Start programme, has your mental health Improved or 
Stayed the same      
 TOTAL _ 
 
 
1. How often do you eat breakfast? 
 Every day (4)      Occasionally (once per month) (1) 
 4 – 6 times per week  (3)  Never  (0)                               
  1-3 times per week (2)     
 
2. How often do you miss meals? 
 Every day (0)      Occasionally (once per month) (3) 
 4 – 6 times per week (1)  Never (4) 
           
 1-3 times per week (2)    
  
 
3. How many days last week did you eat fruit 
and/or veg? 
 
0 (0)   1-2 (1)  3-4 (2)   5-6 (3)   Daily (4) 
 
4. How many portions of fruit and/or veg did you eat per day? (One portion of fruit is a 
medium size apple, banana, 12 grapes, 2 
plums, 7 strawberries or 3 tablespoons 
tinned fruit)    
      
 0 (0)  1-2 (1)  3-4 (2)  5 or more (3) 
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
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5. How often do you eat fried food? 
 (Includes foods that are fried at home, e.g. 
burgers,  
sausages, chips, takeaways, fried chicken) 
         
 Every day (0)       Occasionally (once per month) (3) 
 4 – 6 times per week  (1)  Never  (4)  
 1-3 times per week  (2) 
 Amount_____________ Improvement over previous questionnaire (1) 
 
6.   How often do you snack on biscuits, cakes, sweets, 
 chocolate, ice cream, crisps, pastry, pies? 
   
 Every day (0)       Occasionally (once per month) (3) 
 4 – 6 times per week (1)  Never  (4)  
  1-3 times per week (2) 
 Amount_____________ Improvement over previous questionnaire (1)  
  
 
 
7a. How many days of the week do you drink 
alcohol? 
       
0(4)    1-3 (3)   4-5 (2)   6-7 (1) 
 
    7b. How many units of alcohol do you drink per week? 
 (1 unit is ½ pint beer/lager, 1 single pub measure of spirit, 1 small glass of wine) 
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
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 Females: 0 (3) 1-7 (2) 8-14 (1) 
 >14 (0)   
 Males:  0 (3) 1-11 (2) 12-21 (1)   >21 (0) 
 Amount_____________ Improvement over previous questionnaire (1) 
  
8. How often do you eat oily fish? (e.g. fresh tuna, salmon, mackerel, kippers, trout) 
 
Two or more times a week (3)      Once a week 
(2)   
Less than once a week (1)           Never(0) 
 
9.  Do you overeat when you are upset, anxious, worried, angry or depressed? 
 
Always (0)         
Often (1) 
Sometimes (2)        Never (3) 
 
10. Do you overeat when you are bored? 
 
Always  (0)         
Often (1) 
 Sometimes (2)        Never (3) 
 
11. Do you plan what you are going to eat? 
 
Always (3)        Often 
(2) 
Sometimes (1)       Never (0) 
 
  
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
     
Initial 6 M 12 M 18M Final 
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APPENDIX B: metabolic output questionnaire 
 
Fresh Start Programme 
 
METs Score = 
 
To calculate METS 
 
METS =   (8 × VigorousDays × VigorousMinutes) 
       + (4 × ModerateDays × ModerateMinutes)  
       + (3.3 × WalkingDays × WalkingMinutes) 
  
  
 
 
Physical Activity in a typical week 
  
1a During the last 7 days on how many days did you do vigorous physical activities 
like heavy lifting, digging, aerobics or fast cycling? 
 
      
_______days 
   
1b  How much time in total did you usually spend on one of those days doing 
vigorous physical activities? 
 
 
___Hrs 
 
____ Mins 
   
2a During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles tennis? 
(do not include walking) 
 
         
______days 
   
2b  How much time in total did you usually spend on one of those days doing 
moderate physical activity? 
 
 
___Hrs             
 
____Mins 
   
3a During the last 7 days on how many days did you Walk for at least 10 minutes 
at a time? This includes walking at work and at home, walking to travel place to 
place and any other walking that you might solely do for recreation, sport, 
exercise or leisure 
 
 
 
 
        
_____days 
   
3b  How much time in total did you usually spend walking on one of those days?              
___Hrs 
          
____Mins 
   
3c  At what pace do you usually walk? 
 
  
Vigorous pace             Moderate pace              Slower pace   
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APPENDIX E: care record card 
 
 
